Comparison of differences in blood laboratory results between acute promyelocytic leukemia and acute promyelocytic leukemia+FLT3-internal tandem duplication patients

Comparison of differences in blood laboratory results between acute promyelocytic leukemia and acute promyelocytic leukemia+FLT3-internal tandem duplication patients

BACKGROUND: Acute promyelocytic leukemia (APL) is a well-defined subtype of acute myeloic leukemia (AML) and known by t (15;17)(PML-RARA) mutation. About 20%–40% of AML patients indicate FMS-like tyrosine kinase 3 (FLT3) mutations. FLT3 mutations contain two famous mutations: FLT3-internal tandem du...

Full description

Bibliographic Details
Main Authors: Mehdi Mohammadi Kanesbi, Lida Jarahi, Hossein Ayatollahi, Maryam Sheikhi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Iraqi Journal of Hematology
Subjects:
acute promyelocytic leukemia
blood cells
fms-like tyrosine kinase
internal tandem duplication
laboratory assays
Online Access:http://www.ijhonline.org/article.asp?issn=2072-8069;year=2021;volume=10;issue=1;spage=34;epage=40;aulast=Kanesbi

Internet

http://www.ijhonline.org/article.asp?issn=2072-8069;year=2021;volume=10;issue=1;spage=34;epage=40;aulast=Kanesbi

Similar Items